Previous 10 | Next 10 |
PerkinElmer, Inc. (PKI) Q1 2021 Results Earnings Conference Call May 04, 2021, 5:00 pm ET Company Participants Bryan Kipp - Vice President of Investor Relations Prahlad Singh - President, Chief Executive Officer Jamey Mock - Senior Vice President, Chief Financial Officer Conference Call Parti...
The following slide deck was published by PerkinElmer, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: PerkinElmer, Inc. 2021 Q1 - Results - Earnings Call Presentation
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will host a virtual Investor and Analyst Day on Thursday, June 24, 2021 from 8:30 a.m. to 12:00 p.m. ET. The virtual format will feature presentatio...
PerkinElmer (PKI): Q1 Non-GAAP EPS of $3.72 beats by $0.65; GAAP EPS of $3.37 beats by $0.78.Revenue of $1.31B (+100.7% Y/Y) beats by $100M.For the second quarter of 2021, the Company forecasts GAAP revenue of approximately $1.11 billion vs. $1.21B consensus, GAAP earnings per share from cont...
Revenue of $1.308 billion; 100% reported growth; 92% organic growth GAAP EPS from continuing operations of $3.37; Adjusted EPS of $3.72 Initiates Second Quarter and Raises Full-Year Revenue and Earnings Guidance PerkinElmer, Inc . (NYSE: PKI), a globa...
Thermo Fisher Scientific is a good-quality stock that is well-positioned to grow via M&A and organically in a growing industry. We outline the recent PPD, Inc. acquisition. We perform a DCF valuation to determine Thermo Fisher's fair value. For further details see: T...
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec a global, high-growth diagnostics company part of PerkinElmer (NYSE: PKI), today announced that its T-SPOT ® Discovery SARS-CoV-2 kit will be used for T cell testing in th...
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec, a global, high-growth diagnostics company part of PerkinElmer (NYSE: PKI) , today announced that its T-SPOT ® Discovery SARS-CoV-2 kit will be used for T cell testing in ...
How do we know what is going on #behindthescenes of a company? According to Stock Traders Daily, a 20-year #financialindustry innovator, the best way to do this to to watch the price action in the stock. The Perkinelmer (NYSE: PKI) report below is a real world exam...
Solid biopharma demand, rising diagnostic trends, and the economic recovery will support a ‘healthy’ Q1 revenue growth argues UBS analyst Dan Brennan and the team in a Q1 2021 preview written on the sector of life sciences & diagnostic tools.The firm picks IQVIA Holdings ([[...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...